Page 142 - Clinical Small Animal Internal Medicine
P. 142

110  Section 2  Endocrine Disease

              may be treated with glucagon or dexamethasone.   hypoadrenocorticism is not commonly found as a cause
  VetBooks.ir  Feeding small frequent meals may be beneficial in help­  of hypoglycemia in dogs in the absence of other clinical
                                                              clues. Nonislet cell tumor hypoglycemia is often associ­
              ing to manage hypoglycemia.
               Use antiemetics and gastrointestinal protectants as
            ●
              needed.                                         ated with a large, clinically apparent mesenchymal
                                                              tumor (e.g., leiomyoma and leiomyosarcoma) as well as
               Avoid drugs that are metabolized by the liver.  epithelial tumors that are associated with the liver (e.g.,
            ●
               Antibiotics may be indicated in acute liver failure   hepatoma or hepatocellular carcinoma).
            ●
              cases  to treat concurrent infection (clavamox or   As part of the signalment, age of the animal can be
              amoxicillin, ampicillin, cephalexin, or cefadroxil with   quite useful in narrowing down the long list of rule‐outs
              metronidazole).                                 for hypoglycemia. For example, hypoglycemia in a puppy
                                                              or kitten is often idiopathic in origin or related to starva­
            Duration of Treatment and Prognosis               tion, PSVA, or sepsis. In young adult dogs, hypoglycemia is
            The length of treatment depends on the severity of clini­  usually caused by hepatic insufficiency, hypoadrenocor­
            cal signs. Treatment for cases without liver involvement   ticism, or sepsis. And in older dogs, hepatic insufficiency,
            may last 1–3 days. Treatment should continue until glu­  insulinoma (see Chapter XX), nonislet cell tumor‐induced
            cose levels are normal. Treatment of cases with liver   hypoglycemia, hypoadrenocorticism, and sepsis are the
            involvement may last weeks. The prognosis for patients   most common causes of hypoglycemia.
            that only develop hypoglycemia is good. Prognosis for   The results of routine and specialized tests can also be
            patients who develop liver failure is guarded and depends   quite helpful diagnostically. For example, dogs with adre­
            on the severity of the disease. Typically, there are no lin­  nal insufficiency without the classic electrolyte changes
            gering medical issues once liver problems have been suc­  of hyperkalemia and hyponatremia often have hypoal­
            cessfully resolved.                               buminemia, hypocholesterolemia and a resting cortisol
                                                              <2 μg/dL, although an ACTH response test is required
                                                              for a definitive diagnosis. Paired fasting and postprandial
              Diagnostic Approach to Disorders                serum bile acids are diagnostic for virtually all dogs with
            Associated with Hypoglycemia                      a portosystemic shunt, and CBC findings which include
                                                              a neutrophilic leukocytosis with a left shift in a hypogly­
            After confirming the finding of hypoglycemia, the   cemic febrile dog or cat are highly suggestive of sepsis.
              history  (including  exposure  to  insulin,  sulfonylureas,   When the cause of the hypoglycemic disorder is not
            or xylitol), signalment, physical exam findings, and a   evident in a seemingly well adult dog, serum glucose and
            careful review of available laboratory data guide the   insulin concentrations should be measured during an
            evaluation. This information will either provide clues   episode of spontaneous hypoglycemia to rule out an
            to the cause of hypoglycemia or exclude hypoglycemia   insulinoma. The key pathophysiologic feature of endog­
            caused by acknowledged drugs or toxins, critical ill­  enous hyperinsulinism (e.g., an insulinoma) is the failure
            nesses, hormone deficiencies, or a nonislet cell tumor.   of insulin secretion to fall to very low rates as blood
            A test of adrenocortical function is reasonable although     glucose concentrations fall to hypoglycemic levels.



              Further Reading

            Allison RW, Yeagley T, Levis K, et al. Babesia canis rossi   129th Annual Meeting, March 1–3, 2013, Florham
              infection in a Texas dog. Vet Clin Pathol 2011; 40:   Park, NJ.
              345–50.                                         Cohen M, Post GS, Wright JC. Gastrointestinal
            Baurnstark ME, Sieber‐Ruckstuhl N, Muller C, et al.   leiomyosarcoma in 14 dogs. J Vet Intern Med 2003; 17:
              Evaluation of aldosterone concentrations in dogs with   107–10.
              hypoadrenocorticism. J Vet Intern Med 2014; 28: 154–9.  Cryer PE. Hypoglycemia, functional brain failure, and
            Breitschwerdt EB, Loar A, Hribernik T, McGrath R.   brain death. J Clin Invest 2007; 117: 868–70.
              Hypoglycemia in four dogs with sepsis. J Am Vet Med   Cryer PE, Polansky KS. Glucose homeostasis and
              Assoc 1981; 178: 1072–6.                          hypoglycemia. In: Wilson JD, Foster DW, Kronenberg
            Breitschwerdt EB, Goldkamp C, Castleman W, et al.   HM, Larsen PR, eds. Williams Textbook of Endocrinology,
              Hyperinsulinemic hypoglycemia syndrome in 2 dogs   9th edn. Philadelphia, PA: WB Saunders, 1998.
              with bartonellosis. J Vet Intern Med 2014; 28: 1331–5.  Cryer PE, Axelrod L, Grossman A, et al. Evaluation and
            Center SA. Differentiating portosystemic shunts from   management of adult hypoglycemia. J Clin Endocrinol
              microvascular dysplasia. Paper presented at NJVMA   Metab 2009; 94(3): 709–28.
   137   138   139   140   141   142   143   144   145   146   147